Carcinoma-associated fibroblasts are a rate-limiting determinant for tumour progression

Seminars in Cell and Developmental Biology

Volumn 21, Issue 1, 2010, Pages 19-25

  Shimoda, Masayuki ^a,b   Mellody, Kieran T ^b   Orimo, Akira ^b  

^a KEIO UNIVERSITY   (Japan)

^b UNIVERSITY OF MANCHESTER   (United Kingdom)

Author keywords

Carcinoma associated fibroblasts (CAFs); Fibrosis; SDF 1; Stromal myofibroblasts; TGF ; Wound healing

Indexed keywords

BETA CATENIN; CXCL14 CHEMOKINE; CYCLOOXYGENASE 2; NOTCH1 RECEPTOR; PLATELET DERIVED GROWTH FACTOR C; SCLEROPROTEIN; STROMAL CELL DERIVED FACTOR 1; TRANSFORMING GROWTH FACTOR BETA;

ANGIOGENESIS; BREAST CARCINOMA; CANCER CELL; CANCER GROWTH; CANCER INVASION; CARCINOGENESIS; CARCINOMA ASSOCIATED FIBROBLAST; CELL ACTIVATION; CELL INVASION; CELL TRANSFORMATION; COMPARATIVE GENOMIC HYBRIDIZATION; CYTOKINE RELEASE; DNA MICROARRAY; EPIGENETICS; FIBROBLAST; GENE MUTATION; GENETIC ANALYSIS; HETEROZYGOSITY LOSS; HUMAN; MICROENVIRONMENT; MOLECULAR INTERACTION; MYOFIBROBLAST; PARACRINE SIGNALING; PATHOPHYSIOLOGY; PROTEIN EXPRESSION; REVIEW; SINGLE NUCLEOTIDE POLYMORPHISM; SOMATIC MUTATION; STROMA CELL; TUMOR PROMOTION;

EID: 75849159205     PISSN: 10849521     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.semcdb.2009.10.002     Document Type: Review

References (79)

1. Hanahan D., and Weinberg R.A. The hallmarks of cancer. Cell 100 (2000) 57-70
2. Bissell M.J., and Radisky D. Putting tumours in context. Nat Rev Cancer 1 (2001) 46-54
3. Mueller M.M., and Fusenig N.E. Friends or foes-bipolar effects of the tumour stroma in cancer. Nat Rev Cancer 4 (2004) 839-849
4. Bhowmick N.A., Neilson E.G., and Moses H.L. Stromal fibroblasts in cancer initiation and progression. Nature 432 (2004) 332-337
5. Polyak K., Haviv I., and Campbell I.G. Co-evolution of tumor cells and their microenvironment. Trends Genet 25 (2009) 30-38
6. Orimo A., and Weinberg R.A. Stromal fibroblasts in cancer: a novel tumor-promoting cell type. Cell Cycle 5 (2006) 1597-1601
7. Coussens L.M., and Werb Z. Inflammation and cancer. Nature 420 (2002) 860-867
8. Kalluri R., and Zeisberg M. Fibroblasts in cancer. Nat Rev Cancer 6 (2006) 392-401
9. Guo X., Oshima H., Kitmura T., Taketo M.M., and Oshima M. Stromal fibroblasts activated by tumor cells promote angiogenesis in mouse gastric cancer. J Biol Chem 283 (2008) 19864-19871
10. Noma K., Smalley K.S.M., Lioni M., Naomoto Y., Tanaka N., El-Deiry W., et al. The essential role of fibroblasts in esophageal squamous cell carcinoma-induced angiogenesis. Gastroenterology 134 (2008) 1981-1993
11. Kellermann M.G., Sobral L.M., da Silva S.D., Zecchin K.G., Graner E., Lopes M.A., et al. Mutual paracrine effects of oral squamous cell carcinoma cells and normal oral fibroblasts: induction of fibroblast to myofibroblast transdifferentiation and modulation of tumor cell proliferation. Oral Oncol 44 (2008) 509-517
12. Gabbiani G., Ryan G.B., and Majne G. Presence of modified fibroblasts in granulation tissue and their possible role in wound contraction. Experientia 27 (1971) 549-550
13. Serini G., and Gabbiani G. Mechanisms of myofibroblast activity and phenotypic modulation. Exp Cell Res 250 (1999) 273-283
14. Hinz B., Phan S.H., Thannickal V.J., Galli A., Bochaton-Piallat M.L., and Gabbiani G. The myofibroblast: one function, multiple origins. Am J Pathol 170 (2007) 1807-1816
15. Varga J. Scleroderma and Smads: dysfunctional Smad family dynamics culminating in fibrosis. Arthritis Rheum 46 (2002) 1703-1713
16. Kim K.K., Wei Y., Szekeres C., Kugler M.C., Wolters P.J., Hill M.L., et al. Epithelial cell alpha3beta1 integrin links beta-catenin and Smad signaling to promote myofibroblast formation and pulmonary fibrosis. J Clin Invest 119 (2009) 213-224
17. Mori Y., Chen S.J., and Varga J. Expression and regulation of intracellular SMAD signaling in scleroderma skin fibroblasts. Arthritis Rheum 48 (2003) 1964-1978
18. Hu M., Peluffo G., Chen H., Gelman R., Schnitt S., and Polyak K. Role of COX-2 in epithelial-stromal cell interactions and progression of ductal carcinoma in situ of the breast. Proc Natl Acad Sci USA 106 (2009) 3372-3377
19. Sieweke M.H., Thompson N.L., Sporn M.B., and Bissell M.J. Mediation of wound-related Rous sarcoma virus tumorigenesis by TGF-beta. Science 248 (1990) 1656-1660
20. Demehri S., Turkoz A., and Kopan R. Epidermal Notch1 loss promotes skin tumorigenesis by impacting the stromal microenvironment. Cancer Cell 16 (2009) 55-66
21. Sappino A.P., Skalli O., Jackson B., Schurch W., and Gabbiani G. Smooth-muscle differentiation in stromal cells of malignant and non-malignant breast tissues. Int J Cancer 41 (1988) 707-712
22. Orimo A., Gupta P.B., Sgroi D.C., Arenzana-Seisdedos F., Delaunay T., Naeem R., et al. Stromal fibroblasts present in invasive human breast carcinomas promote tumor growth and angiogenesis through elevated SDF-1/CXCL12 secretion. Cell 121 (2005) 335-348
23. Dvorak H.F. Tumors: wounds that do not heal. Similarities between tumor stroma generation and wound healing. N Engl J Med 315 (1986) 1650-1659
24. Ronnov-Jessen L., Petersen O.W., and Bissell M.J. Cellular changes involved in conversion of normal to malignant breast: importance of the stromal reaction. Physiol Rev 76 (1996) 69-125
25. Schafer M., and Werner S. Cancer as an overhealing wound: an old hypothesis revisited. Nat Rev Mol Cell Biol 9 (2008) 628-638
26. Maeshima A.M., Niki T., Maeshima A., Yamada T., Kondo H., and Matsuno Y. Modified scar grade: a prognostic indicator in small peripheral lung adenocarcinoma. Cancer 95 (2002) 2546-2554
27. Cardone A., Tolino A., Zarcone R., Borruto Caracciolo G., and Tartaglia E. Prognostic value of desmoplastic reaction and lymphocytic infiltration in the management of breast cancer. Panminerva Med 39 (1997) 174-177
28. Olumi A.F., Grossfeld G.D., Hayward S.W., Carroll P.R., Tlsty T.D., and Cunha G.R. Carcinoma-associated fibroblasts direct tumor progression of initiated human prostatic epithelium. Cancer Res 59 (1999) 5002-5011
29. Hwang R.F., Moore T., Arumugam T., Ramachandran V., Amos K.D., Rivera A., et al. Cancer-associated stromal fibroblasts promote pancreatic tumor progression. Cancer Res 68 (2008) 918-926
30. Sneddon J.B., Zhen H.H., Montgomery K., van de Rijn M., Tward A.D., West R., et al. Bone morphogenetic protein antagonist gremlin 1 is widely expressed by cancer-associated stromal cells and can promote tumor cell proliferation. Proc Natl Acad Sci USA 103 (2006) 14842-14847
31. De Wever O., Nguyen Q.D., Van Hoorde L., Bracke M., Bruyneel E., Gespach C., et al. Tenascin-C and SF/HGF produced by myofibroblasts in vitro provide convergent pro-invasive signals to human colon cancer cells through RhoA and Rac. FASEB J 18 (2004) 1016-1018
32. Zhang C., Fu L., Fu J., Hu L., Yang H., Rong T.H., et al. Fibroblast growth factor receptor 2-positive fibroblasts provide a suitable microenvironment for tumor development and progression in esophageal carcinoma. Clin Cancer Res 15 (2009) 4017-4027
33. Yang G., Rosen D.G., Zhang Z., Bast Jr. R.C., Mills G.B., Colacino J.A., et al. The chemokine growth-regulated oncogene 1 (Gro-1) links RAS signaling to the senescence of stromal fibroblasts and ovarian tumorigenesis. Proc Natl Acad Sci USA 103 (2006) 16472-16477
34. Allinen M., Beroukhim R., Cai L., Brennan C., Lahti-Domenici J., Huang H., et al. Molecular characterization of the tumor microenvironment in breast cancer. Cancer Cell 6 (2004) 17-32
35. Mercier I., Casimiro M.C., Wang C., Rosenberg A.L., Quong J., Minkeu A., et al. Human breast cancer-associated fibroblasts (CAFs) show caveolin-1 downregulation and RB tumor suppressor functional inactivation: implications for the response to hormonal therapy. Cancer Biol Ther 7 (2008) 1212-1225
36. Micke P., Kappert K., Ohshima M., Sundquist C., Scheidl S., Lindahl P., et al. In situ identification of genes regulated specifically in fibroblasts of human basal cell carcinoma. J Invest Dermatol 127 (2007) 1516-1523
37. Dakhova O., Ozen M., Creighton C.J., Li R., Ayala G., Rowley D., et al. Global gene expression analysis of reactive stroma in prostate cancer. Clin Cancer Res 15 (2009) 3979-3989
38. Yang F., Tuxhorn J.A., Ressler S.J., McAlhany S.J., Dang T.D., and Rowley D.R. Stromal expression of connective tissue growth factor promotes angiogenesis and prostate cancer tumorigenesis. Cancer Res 65 (2005) 8887-8895
39. Ao M., Franco O.E., Park D., Raman D., Williams K., and Hayward S.W. Cross-talk between paracrine-acting cytokine and chemokine pathways promotes malignancy in benign human prostatic epithelium. Cancer Res 67 (2007) 4244-4253
40. San Francisco I.F., DeWolf W.C., Peehl D.M., and Olumi A.F. Expression of transforming growth factor-beta 1 and growth in soft agar differentiate prostate carcinoma-associated fibroblasts from normal prostate fibroblasts. Int J Cancer 112 (2004) 213-218
41. Rosenthal E., McCrory A., Talbert M., Young G., Murphy-Ullrich J., and Gladson C. Elevated expression of TGF-beta1 in head and neck cancer-associated fibroblasts. Mol Carcinogen 40 (2004) 116-121
42. Haviv I., Polyak K., Qiu W., Hu M., and Campbell I. Origin of carcinoma associated fibroblasts. Cell Cycle 8 (2009) 589-595
43. Weinberg R.A. Coevolution in the tumor microenvironment. Nat Genet 40 (2008) 494-495
44. Moinfar F., Man Y.G., Arnould L., Bratthauer G.L., Ratschek M., and Tavassoli F.A. Concurrent and independent genetic alterations in the stromal and epithelial cells of mammary carcinoma: implications for tumorigenesis. Cancer Res 60 (2000) 2562-2566
45. Wernert N., Locherbach C., Wellmann A., Behrens P., and Hugel A. Presence of genetic alterations in microdissected stroma of human colon and breast cancers. Anticancer Res 21 (2001) 2259-2264
46. Kurose K., Gilley K., Matsumoto S., Watson P.H., Zhou X.P., and Eng C. Frequent somatic mutations in PTEN and TP53 are mutually exclusive in the stroma of breast carcinomas. Nat Genet 32 (2002) 355-357
47. Patocs A., Zhang L., Xu Y., Weber F., Caldes T., Mutter G.L., et al. Breast-cancer stromal cells with TP53 mutations and nodal metastases. N Engl J Med 357 (2007) 2543-2551
48. Tuhkanen H., Anttila M., Kosma V.M., Yla-Herttuala S., Heinonen S., Kuronen A., et al. Genetic alterations in the peritumoral stromal cells of malignant and borderline epithelial ovarian tumors as indicated by allelic imbalance on chromosome 3p. Int J Cancer 109 (2004) 247-252
49. Paterson R.F., Ulbright T.M., MacLennan G.T., Zhang S., Pan C.X., Sweeney C.J., et al. Molecular genetic alterations in the laser-capture-microdissected stroma adjacent to bladder carcinoma. Cancer 98 (2003) 1830-1836
50. Weber F., Xu Y., Zhang L., Patocs A., Shen L., Platzer P., et al. Microenvironmental genomic alterations and clinicopathological behavior in head and neck squamous cell carcinoma. JAMA 297 (2007) 187-195
51. Hill R., Song Y., Cardiff R.D., and Van Dyke T. Selective evolution of stromal mesenchyme with p53 loss in response to epithelial tumorigenesis. Cell 123 (2005) 1001-1011
52. Kiaris H., Chatzistamou I., Trimis G., Frangou-Plemmenou M., Pafiti-Kondi A., and Kalofoutis A. Evidence for nonautonomous effect of p53 tumor suppressor in carcinogenesis. Cancer Res 65 (2005) 1627-1630
53. Tokudome N., Sakamoto G., Sakai T., Sarumaru S., Okuyama N., Hori F., et al. A case of carcinosarcoma of the breast. Breast Cancer 12 (2005) 149-153
54. Bolton B., and Sieunarine K. Carcinosarcoma: a rare tumour of the breast. Aust N Z J Surg 60 (1990) 917-919
55. Qiu W., Hu M., Sridhar A., Opeskin K., Fox S., Shipitsin M., et al. No evidence of clonal somatic genetic alterations in cancer-associated fibroblasts from human breast and ovarian carcinomas. Nat Genet 40 (2008) 650-655
56. Walter K., Omura N., Hong S.M., Griffith M., and Goggins M. Pancreatic cancer associated fibroblasts display normal allelotypes. Cancer Biol Ther 7 (2008) 882-888
57. Jiang L., Gonda T.A., Gamble M.V., Salas M., Seshan V., Tu S., et al. Global hypomethylation of genomic DNA in cancer-associated myofibroblasts. Cancer Res 68 (2008) 9900-9908
58. Hu M., Yao J., Cai L., Bachman K.E., van den Brule F., Velculescu V., et al. Distinct epigenetic changes in the stromal cells of breast cancers. Nat Genet 37 (2005) 899-905
59. Kalluri R., and Weinberg R.A. The basics of epithelial-mesenchymal transition. J Clin Invest 119 (2009) 1420-1428
60. Ishii G., Sangai T., Oda T., Aoyagi Y., Hasebe T., Kanomata N., et al. Bone-marrow-derived myofibroblasts contribute to the cancer-induced stromal reaction. Biochem Biophys Res Commun 309 (2003) 232-240
61. Direkze N.C., Hodivala-Dilke K., Jeffery R., Hunt T., Poulsom R., Oukrif D., et al. Bone marrow contribution to tumor-associated myofibroblasts and fibroblasts. Cancer Res 64 (2004) 8492-8495
62. Mishra P.J., Mishra P.J., Humeniuk R., Medina D.J., Alexe G., Mesirov J.P., et al. Carcinoma-associated fibroblast-like differentiation of human mesenchymal stem cells. Cancer Res 68 (2008) 4331-4339
63. Zeisberg E.M., Potenta S., Xie L., Zeisberg M., and Kalluri R. Discovery of endothelial to mesenchymal transition as a source for carcinoma-associated fibroblasts. Cancer Res 67 (2007) 10123-10128
64. Radisky D.C., Kenny P.A., and Bissell M.J. Fibrosis and cancer: do myofibroblasts come also from epithelial cells via EMT?. J Cell Biochem 101 (2007) 830-839
65. Ronnov-Jessen L., Petersen O.W., Koteliansky V.E., and Bissell M.J. The origin of the myofibroblasts in breast cancer. Recapitulation of tumor environment in culture unravels diversity and implicates converted fibroblasts and recruited smooth muscle cells. J Clin Invest 95 (1995) 859-873
66. Tait L.R., Pauley R.J., Santner S.J., Heppner G.H., Heng H.H., Rak J.W., et al. Dynamic stromal-epithelial interactions during progression of MCF10DCIS.com xenografts. Int J Cancer 120 (2007) 2127-2134
67. Augsten M., Hagglof C., Olsson E., Stolz C., Tsagozis P., Levchenko T., et al. CXCL14 is an autocrine growth factor for fibroblasts and acts as a multi-modal stimulator of prostate tumor growth. Proc Natl Acad Sci USA 106 (2009) 3414-3419
68. Crawford Y., Kasman I., Yu L., Zhong C., Wu X., Modrusan Z., et al. PDGF-C mediates the angiogenic and tumorigenic properties of fibroblasts associated with tumors refractory to anti-VEGF treatment. Cancer Cell 15 (2009) 21-34
69. Pietras K., Pahler J., Bergers G., and Hanahan D. Functions of paracrine PDGF signaling in the proangiogenic tumor stroma revealed by pharmacological targeting. PLoS Med 5 (2008) e19
70. Fidler I.J. The pathogenesis of cancer metastasis: the 'seed and soil' hypothesis revisited. Nat Rev Cancer 3 (2003) 453-458
71. Karnoub A.E., Dash A.B., Vo A.P., Sullivan A., Brooks M.W., Bell G.W., et al. Mesenchymal stem cells within tumour stroma promote breast cancer metastasis. Nature 449 (2007) 557-563
72. Surowiak P., Suchocki S., Gyorffy B., Gansukh T., Wojnar A., Maciejczyk A., et al. Stromal myofibroblasts in breast cancer: relations between their occurrence, tumor grade and expression of some tumour markers. Folia Histochem Cytobiol 44 (2006) 111-116
73. Le N.H., Franken P., and Fodde R. Tumour-stroma interactions in colorectal cancer: converging on beta-catenin activation and cancer stemness. Br J Cancer 98 (2008) 1886-1893
74. Weinberg R.A. The biology of cancer (2007), Garland Science, New York
75. Fukumura D., Xavier R., Sugiura T., Chen Y., Park E.C., Lu N., et al. Tumor induction of VEGF promoter activity in stromal cells. Cell 94 (1998) 715-725
76. Zhu C.Q., Popova S.N., Brown E.R., Barsyte-Lovejoy D., Navab R., Shih W., et al. Integrin alpha 11 regulates IGF2 expression in fibroblasts to enhance tumorigenicity of human non-small-cell lung cancer cells. Proc Natl Acad Sci USA 104 (2007) 11754-11759
77. Tokunou M., Niki T., Eguchi K., Iba S., Tsuda H., Yamada T., et al. c-MET expression in myofibroblasts: role in autocrine activation and prognostic significance in lung adenocarcinoma. Am J Pathol 158 (2001) 1451-1463
78. Joesting M.S., Perrin S., Elenbaas B., Fawell S.E., Rubin J.S., Franco O.E., et al. Identification of SFRP1 as a candidate mediator of stromal-to-epithelial signaling in prostate cancer. Cancer Res 65 (2005) 10423-10430
79. Degen M., Brellier F., Kain R., Ruiz C., Terracciano L., Orend G., et al. Tenascin-W is a novel marker for activated tumor stroma in low-grade human breast cancer and influences cell behavior. Cancer Res 67 (2007) 9169-9179